>

Stephen Doster

  • Vanderbilt University

    Brenda Crews

    With a heavy heart, we share that Brenda Crews, senior research specialist of the Marnett Lab in the Department of Biochemistry, has passed away. A loyal ‘Dore, Brenda was with Vanderbilt for more than 40 years, and a member of the Marnett lab for nearly 30 of those years! Lab… Read More

    Jan. 19, 2022

  • Vanderbilt University

    The role of integrins in kidney “integrity”

    Jan. 13, 2022, 10:40 AM by Bill Snyder Transmembrane receptors called integrins and proteins called laminins play important roles in the formation and function of tissues, including the ducts that collect urine from the filtering units of the kidneys.  To better understand their role, Roy Zent,… Read More

    Jan. 13, 2022

  • New Awards Announced for Postdoctoral Scholars in Biochemistry

    New Awards Announced for Postdoctoral Scholars in Biochemistry

    By Dave Cortez and Aaron Conley The Department of Biochemistry at Vanderbilt University School of Medicine Basic Sciences announced new annual awards for postdoctoral scholars called the Destination Biochemistry Postdoctoral Scholar Awards. These awards will support exceptional postdoctoral fellows from around the world as they join labs in the Department… Read More

    Jan. 10, 2022

  • Vanderbilt University

    Vanderbilt scientist’s team project wins $55,000 to research fundamental cell behavior

    Lars Plate, assistant professor of chemistry and biological sciences, is on a team that won $55,000 from Scialog’s initiative, Chemical Machinery of the Cell. The award—one of 24 granted to 21 researchers in the U.S. and Canada—will enable… Read More

    Jan. 7, 2022

  • Vanderbilt University

    Study explores how bacteria become drug resistant

    Researchers at Vanderbilt University and the University of Arizona have revealed more of the inner-workings of a two-stage “molecular motor” in the cell membrane that enables bacteria to become resistant to drugs. Their findings, which were reported recently in the journal Nature Chemical Biology, will aid the search for inhibitors… Read More

    Jan. 6, 2022

  • Vanderbilt University

    Vanderbilt extends its longest ongoing drug discovery agreement with pharmaceutical company through 2023

    Vanderbilt has extended its longest ongoing drug discovery agreement with Osaka, Japan-based Ono Pharmaceutical Co., Ltd., a research and development-oriented pharmaceutical company that is committed to creating innovative medicines in specific areas, through November 2023. The initial agreement was signed in November… Read More

    Dec. 22, 2021

  • Vanderbilt University

    Study sets framework for precision surveillance of colorectal cancer

    by Tom Wilemon A team of Vanderbilt researchers has revealed some of the mechanisms by which polyps develop into colorectal cancer, setting the framework for improved surveillance for the cancer utilizing precision medicine. Their study, published Dec. 14 in Cell, describes findings from a single-cell transcriptomic and imaging atlas… Read More

    Dec. 17, 2021

  • On a dark green background, several short pieces of DNA “float” around. One is vertical on the left side of the image, and a zoomed-in portion is seen horizonally on the right. The DNA on its side has more details (it’s a stick model) and shows water molecules (also stick models) surrounding the DNA. Hydrogen bonds between the water and the DNA are visualized as yellow dashes.

    Neutrons take a deep dive into water networks surrounding DNA

    By Olivia Trani This article was originally published on the Oak Ridge National Laboratory website and was adapted with permission for publication at Vanderbilt University. Water plays several important roles within the human body, even affecting the DNA in our cells. The entire surface of a DNA… Read More

    Dec. 17, 2021

  • Dr. James Crowe Jr., professor of medicine, in his lab at Medical Research Building IV. Dr. Crowe is the subject of a feature article in the upcoming Winter 2018 issue of Vanderbilt Magazine. Crowe, who is the Ann Scott Carell Professor of Pediatrics, Pathology, Microbiology and Immunology, as well as director of the Vanderbilt Vaccine Center, has spent his career hunting for a universal flu vaccine. He has re-engineered how flu vaccines work and is on the edge of creating a single shot that covers all flu strains. In a new initiative announced in October, he will lead an international team of researchers as they launch clinical trials of his new vaccine.(John Russell/Vanderbilt University)

    Antibodies discovered at Vanderbilt for prevention of COVID-19 granted FDA emergency use authorization

    On Wednesday, the U.S. Food and Drug Administration granted emergency use authorization (EUA) to the global biopharmaceutical company AstraZeneca for a long-acting antibody combination which  protects against COVID-19, discovered last year at Vanderbilt University Medical Center (VUMC). A number of medical conditions result in immune compromise, from treatments for many cancers… Read More

    Dec. 9, 2021

  • Vanderbilt University

    McLean elected as 2021 National Academy of Inventors Fellow

    John McLean, Stevenson Professor of Chemistry, Stevenson Chair and the director of the Center for Innovative Technologies, has been elected a 2021 Fellow of the National Academy of Inventors… Read More

    Dec. 8, 2021